This post is presented by our media partner Cannabis News Wire
View the original article here.
According to a recent study, individuals who use cannabis are less likely to die, require a ventilator or suffer from extreme COVID-19 infections. Researchers from New York’s Northwell Health conducted the study, which was just released in the peer-reviewed “Cannabis and Cannabinoid Research” journal.
The study analyzed the National Inpatient Sample Database’s data, focusing on patients admitted with a COVID-19 diagnosis. The patients were divided into two groups: those who used marijuana and those who did not. To ensure fairness, researchers adjusted for various factors, such as race, age, gender and existing health conditions.
Cannabis users had a lower risk of passing away or developing major conditions, including respiratory failure or the need for intubation, according to the study.
According to the data, 28.2% of marijuana users experienced extreme COVID-19 infections, compared to 46.6% of those who did not use marijuana. The death rate among marijuana users was 2.8%, while it was higher at 5.1% for nonusers. Similarly, intubation rates were lower for marijuana users at 7.1%, compared to 9.7% for nonusers. Marijuana users also spent slightly less time in the hospital, with an average stay of 6.4 days versus 7.0 days for those who didn’t use cannabis.
However, Dr. Benjamin Caplan, a medical cannabis expert and author of “The Doctor-Approved Cannabis Handbook,” pointed out some limitations in the study. These include difficulties in properly matching the patients and a lack of specific data, such as the types of products used and the levels of inflammation in patients.
Despite these limitations, Caplan stated that the results were encouraging. He suggested that cannabis could help avoid severe COVID-19 effects by reducing inflammation and immunological reactions.
Further supporting these findings, a 2022 study indicated that certain marijuana compounds might prevent SARS-CoV-2, the virus responsible for COVID-19, from infecting human cells in a lab setting. Researchers discovered that two cannabinoid acids found in hemp, cannabidiolicacid (CBDA) and cannabigerolic acid (CBGA), could bind to the spike protein of the virus. By doing so, these compounds might block the virus from entering cells and causing an infection, opening up potential new treatment and prevention options.
Similarly, a recent Canadian study discovered that by keeping the virus out of cells, lowering oxidative stress and stopping the cytokine storm, cannabinoids may help lessen the severity of COVID-19 infections.
However, not all studies paint a positive picture of marijuana use in relation to COVID-19. Research from the University of Washington, published earlier this year, found that cannabis use was associated with a higher risk of severe COVID-19. Additionally, there is no concrete evidence that smoking cannabis can cure or prevent COVID-19.
As more studies are conducted on the potential therapeutic effects of marijuana on the way people fared during the recent pandemic, there is a possibility that the science could show that the cannabis industry and its many actors, such as Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), might have in one way or the other supported some people in their struggle against the infection.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
This post was originally published by our media partner here.
